VRP-1620

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVRP-1620
Drug Alias NameTumatrekEndothelin - Venus RemediesVRP-1620
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionEndothelin receptor type B antagonists
TargetsEndothelin receptor type B
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of IllinoisVenus Remedies Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A